Target	Probe	Control	Targeted domain	Mode of action	Recommended concentration	Target origin
EP300, CREBBP	A-485	A-486	HAT domain	Inhibitor	0.8 µM	human
BRD7, BRD9	VZ185	cisVZ185	—	PROTAC degrader	300 nM	human
SMARCA2, SMARCA4	FHT-2344	FHT-5908	—	Inhibitor	≤ 1 µM	human
BRD2, BRD3, BRD4, BRDT	GSK046	no record.controls	BD2	Inhibitor	≤ 10 µM	human
BRD2, BRD3, BRD4, BRDT	GSK620	no record.controls	BD2	Inhibitor	≤ 10 µM	human
BRD2, BRD3, BRD4, BRDT	GSK778	no record.controls	BD1	Inhibitor	≤ 1 µM	human
BRD2, BRD3, BRD4, BRDT	GSK789	GSK791	BD1	Inhibitor	≤ 10 µM	human
BRD2, BRD3, BRD4, BRDT	GSK973	GSK943	BD2	Inhibitor	≤ 10 µM	human
KAT6A, KAT6B	WM-1119	WM-2474	AcCoA binding site	Inhibitor	1 µM (≤ 10 µM)	human